Echo Therapeutics

Needle-free transdermal glucose monitor for critical care patients gets positive trial results

A needle-free, transdermal glucose monitoring device for critical care patients has generated positive results in the second of two clinical trials. The study for Echo Therapeutics‘ (NASDAQ:ECTE) Symphony system was performed at Thomas Jefferson University Hospital. It enrolled 15 adult patients in critical care settings undergoing major general surgery and cardiothoracic surgery. Reference blood samples […]

By Stephanie Baum

News

Painfree glucose monitoring system clinical trial nets positive results

A medical device company with a needlefree glucose monitoring system that keeps a constant read of glucose levels in the blood has achieved positive clinical trial results in a study to monitor patients in a critical care setting. The study at Tufts University included 15 adult patients scheduled for elective cardiac surgery. Echo Therapeutics’ (NASDAQ: […]

By Stephanie Baum

With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?

Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.

Hospitals

Glucose monitor gives continuous reading with needle-free technology

A medical device company with a glucose monitoring system offering needle-free technology providing a constant reading of glucose levels for diabetics sees opportunities for transdermal drug-delivery uses for the product. Echo Therapeutics (NASDAQ:ECTE) is poised to begin a new clinical trial of its glucose monitoring system next month, this time for critical care patients. The […]

By Stephanie Baum

Devices & Diagnostics

Echo Therapeutics’ ECTE moves from OTC to the NASDAQ

Echo Therapeutics (OTC:ECTE) announced that its common stock, previously granted Over-the-Counter status, has graduated to the NASDAQ exchange. The stock will continue to trade under the “ECTE” symbol. “We welcome Echo Therapeutics, Inc. to the NASDAQ family of listed healthcare companies,” said Robert McCooey, Jr., senior VP of New Listings and Capital Markets, NASDAQ OMX. […]

By MassDevice Staff